Listen Live

Current Weather

Loading advertisement…

Novo Nordisk’s weight-loss pill boom faces price war test

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies. Investors now want proof that fast-rising prescriptions can offset a bruising price war... Read More.

EssilorLuxottica CEO confident in share price recovery over time

By Elisa Anzolin PARIS, April 28 (Reuters) - The head of EssilorLuxottica expressed confidence on Tuesday that shares in the Franco-Italian eyewear group can recover the ground lost due to U.S. tariffs, a weaker dollar, military conflicts and competition on smart eyeglasses. Speaking at the company's... Read More.